Masakazu Fujio

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 76(Granted Patents)

Location History:

Iruma, JP (2002)
Kokubunji, JP (2006)
Fuchu, JP (2009 - 2014)
Tokyo, JP (2007 - 2021)
Osaka, JP (2012 - 2023)

Company Filing History:

Mitsubishi Tanabe Pharma Corporation

patents

2 out of 73

Mitsubishi Pharma Corporation

patents

4. 1 out of 365

Hitachi Consumer Electronics Co., Ltd.

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12355890 - Authentication apparatus and authentication method (2025-07-08),

2. 11667602 - Compounds and their use (2023-06-06),

3. 11115214 - Biometric signature system and biometric signature method (2021-09-07),

4. 11018876 - Signature verification system, signature verification method, and storage medium (2021-05-25),

5. 10719593 - Biometric signature system and biometric certificate registration method (2020-07-21),

6. 8774705 - Learning support system and learning support method (2014-07-08),

7. 8309573 - Salt of isoquinoline compound and crystal thereof (2012-11-13),

8. 7812178 - Isoquinoline compound and pharmaceutical use thereof (2010-10-12),

9. 7590651 - Search apparatus (2009-09-15),

10. 7501412 - Isoquinoline compounds and medicinal use thereof (2009-03-10),

11. 7459465 - Isoquinoline compound and pharmaceutical use thereof (2008-12-02),

12. 7220759 - Isoquinoline compound and pharmaceutical use thereof (2007-05-22),

13. 7047255 - Document information display system and method, and document search method (2006-05-16),

14. 6468998 - Pyrrolidine compounds and medicinal utilization thereof (2002-10-22),

Title: Masakazu Fujio: Innovator in Authentication and Therapeutic Compounds

Introduction

Masakazu Fujio is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of authentication technology and pharmaceutical compounds. With a total of 14 patents, his work has had a considerable impact on both technology and healthcare.

Latest Patents

Fujio's latest patents include an innovative authentication apparatus and method. This apparatus utilizes a combination of a concealment template generated from a secret key and biometric information through biometric cryptography. It is designed to extract the secret key from the concealment template using the user's biometric information. The apparatus then acquires identity verification information by decrypting encrypted data with the extracted secret key, ultimately verifying the user's identity. Another notable patent involves compounds that are modulators of RXFP1, which may serve as therapeutic agents for various diseases, including heart failure and chronic kidney disease. These compounds and their compositions are crucial for developing treatments and preventive measures for serious health conditions.

Career Highlights

Throughout his career, Masakazu Fujio has worked with leading companies such as Hitachi, Ltd. and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in his fields of expertise.

Collaborations

Fujio has collaborated with notable colleagues, including Hiroyuki Satoh and Shinya Inoue. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful technologies and compounds.

Conclusion

Masakazu Fujio's contributions to authentication technology and therapeutic compounds highlight his role as a significant inventor. His work continues to influence advancements in both technology and healthcare, showcasing the importance of innovation in improving lives.

This text is generated by artificial intelligence and may not be accurate.